SCHEMBL734660

SCHEMBL734660

CCCc1c(C2=CCC(Cc3ccccc3)(N(C)C)CC2)[nH]c2ccccc12

nearest known ligand 0.44

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
OPRM1 P35372 4/20 0.44
OGFRL1 Q5TC84 1/20 0.44
HTR2A P28223 6/20 0.40
HTR2C P28335 6/20 0.40
DRD2 P14416 4/20 0.40
OPRL1 P41146 3/20 0.38
PPARG P37231 2/20 0.37
ALDH1A1 P00352 2/20 0.36
POLB P06746 1/20 0.36
OPRK1 P41145 1/20 0.36
RAB9A P51151 1/20 0.35
KDM4E B2RXH2 1/20 0.34
HPGD P15428 1/20 0.34
MEN1 O00255 1/20 0.34
KMT2A Q03164 1/20 0.34
ATM Q13315 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3932517 0.90 OPRM1 (0.47) OPRM1OGFRL1HTR2AHTR2CDRD2
SCHEMBL736123 0.90 POLB (0.45) OPRM1OGFRL1HTR2AHTR2CDRD2
Hydrochloric Acid SCHEMBL734199 0.89 OPRM1 (0.46) OPRM1OGFRL1HTR2AHTR2CDRD2
SCHEMBL733852 0.87 OPRM1 (0.41) OPRM1OGFRL1HTR2AHTR2C
SCHEMBL734577 0.87 EGFR (0.46) OPRM1OGFRL1HTR2AHTR2COPRL1
SCHEMBL733728 0.87 HTR2A (0.39) OPRM1HTR2AHTR2CDRD2OPRL1
SCHEMBL735918 0.84 OPRM1 (0.47) OPRM1OGFRL1HTR2AHTR2COPRL1
SCHEMBL734449 0.83 OPRM1 (0.42) OPRM1OGFRL1HTR2AHTR2CDRD2
SCHEMBL733644 0.83 OPRM1 (0.41) OPRM1OGFRL1HTR2AHTR2CDRD2
Hydrochloric Acid SCHEMBL733593 0.82 OPRM1 (0.41) OPRM1OGFRL1HTR2AHTR2CDRD2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2044016-B1 4-HETEROARYL-SUBSTITUTED 1-AMINOCYCLOHEXANE-1-AND CYCLOHEXENE-1-DERIVATIVES HAVING EFFECTS ON THE OPIOD RECEPTOR SYSTEM GRUENENTHAL GMBH (DE) 2012-12-05 EP claimed
US-8138187-B2 Substituted heteroaryl derivatives GRUENENTHAL GMBH (DE) 2012-03-20 US claimed
US-20100009986-A1 SUBSTITUTED HETEROARYL DERIVATIVES GRUNENTHAL GMBH (DE) 2010-01-14 US claimed
EP-2044016-B1 4-HETEROARYL-SUBSTITUTED 1-AMINOCYCLOHEXANE-1-AND CYCLOHEXENE-1-DERIVATIVES HAVING EFFECTS ON THE OPIOD RECEPTOR SYSTEM GRUENENTHAL GMBH (DE) 2012-12-05 EP disclosed
US-8138187-B2 Substituted heteroaryl derivatives GRUENENTHAL GMBH (DE) 2012-03-20 US disclosed
US-20100009986-A1 SUBSTITUTED HETEROARYL DERIVATIVES GRUNENTHAL GMBH (DE) 2010-01-14 US disclosed
EP-2044016-A2 4-HETEROARYL-SUBSTITUTED 1-AMINOCYCLOHEXANE-1-AND CYCLOHEXENE-1-DERIVATIVES HAVING EFFECTS ON THE OPIOD RECEPTOR SYSTEM Grünenthal GmbH (DE) 2009-04-08 EP disclosed
WO-2008009415-A2 4-HETEROARYL-SUBSTITUTED 1-AMINOCYCLOHEXANE-1- AND CYCLOHEXENE-1-DERIVATIVES HAVING EFFECTS ON THE OPIOD RECEPTOR SYSTEM Grünenthal GmbH (DE) 2008-01-24 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100009986-A1 SUBSTITUTED HETEROARYL DERIVATIVES CYP3A43, HMGCR, ABCG2 OPRM1 1029/4885OGFRL1 4373/4885HTR2A 238/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.